Skip to main content
OpenTrials
Completed

NCT Number: NCT01786928

The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease Exacerbation

The purpose of this study is to determine whether resistance exercise are effective in combating the decline in muscle strength during an exacerbation of Chronic Obstructive Pulmonary Disease (COPD).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of sao paulo

São Paulo, 05508-000, Brazil

About this study

Acute exacerbations are common in patients with COPD and cause specific signs and symptoms, such as increased dyspnea, productive cough with altered sputum, and fever. With disease progression, exacerbations are frequent and have a negative impact on health related quality of life and pulmonary function as well as increase mortality. More severe exacerbations require hospitalization resulting in enormous health expenditures, severely reducing daily life activities and declining peripheral muscle strength that can be only partially reversed after 3 months. Despite many features have been pointed out as responsible for the decrease in muscle strength during hospitalization, physical inactivity seems the most important.

Resistance training is an interesting therapeutic option to prevent and/or reverse muscular dysfunction due to immobilised in healthy subjects and stable COPD patients because induces hypertrophy of type II fibers, increases muscle strength and exercise tolerance. In addition, provokes lower dyspnea perception during effort compared with other exercise training. Despite these benefits for stable COPD, the impact of a resistance exercise program during hospitalization remains poorly known.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients hospitalized for exacerbation of COPD

Exclusion criteria

  • patients presenting change in mental status (confusion, lethargy or coma)
  • persistence or worsening in hypoxemia (PaO2<40mmHg) and/or respiratory acidosis (pH<7.25) despite oxygen supplementation or use of non-invasive ventilation
  • hemodynamic instability requiring vasoactive drugs
  • patients transferred to ICU
  • hospitalization lower than 5 days
  • diseases that prevented the exercises

Treatment and study plan

Resistance training

Other

Resistance training group received training program for upper (shoulder flexion and abduction and biceps) and lower limbs (knee extension and flexion and hip flexion). Daily exercise for every muscle was performed with free weights at 80% of an maximal repetition test and a 4 minutes rest was allowed between each step.

Primary outcomes

  1. The benefits of resistance training during exacerbation of COPD on peripheral muscle strength during hospitalization

    Time frame: Will be evaluated on the second day of hospitalization, the day of hospital discharge (this time interval must be longer than five days)

    The metric used to evaluate the strength gain is given in kilogram (absolute value) and percentage relative to that obtained on the second hospital day

Secondary outcomes

  1. The benefits of resistance training during exacerbation of COPD on physical activity in daily life

    Time frame: Will be evaluated in the third and fifth day of hospitalization and thirty days after discharge

    The metric used to evaluate the changes will be given in minutes and percentage of total time

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Registry information

Official study title

Impact of Resistance Training During Hospitalization in COPD Patients: a Randomized and Controlled Trial

Acronym: RECOPD

Important dates

Study start
2009
Primary completion
2009
Study completion
2010
First posted
Feb 8, 2013
Registry last updated
Feb 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.